You are here

• Home
• Therapy Areas
• Cardiovascular

• An open label, randomized, two-period, crossover study to assess the effect of food on fixed dose combination dapagliflozin/metformin tablet (5 mg/1000 mg) in healthy male and female volunteers

Disease

diabetes mellitus

Drug Name

dapagliflozin

Generic Name

dapagliflozin

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

I

Start Date

Jun 29, 2010

Study Name

D1691C00005

Study Id

D1691C00005

ClinicalTrials.gov ID

NCT01156246

Recruiting Status

Closed

Protocol Status

Not Available

Report

Dec 3, 2010

• D1691C00005.pdf (96 KB)

Page tools

• Print
• Bookmark this page